62 related articles for article (PubMed ID: 16498555)
1. [Brief coxib therapy lowers cardiovascular risk].
Z Orthop Ihre Grenzgeb; 2006; 144(1):18. PubMed ID: 16498555
[No Abstract] [Full Text] [Related]
2. Bullous fixed drug eruption to etoricoxib--further evidence of intraepidermal CD8+ T cell involvement.
Duarte AF; Correia O; Azevedo R; do Carmo Palmares M; Delgado L
Eur J Dermatol; 2010; 20(2):236-8. PubMed ID: 20110201
[No Abstract] [Full Text] [Related]
3. [3 questions about gastrointestinal risk. Are coxibs here clearly better than NSAID?]].
Krüger K
MMW Fortschr Med; 2006 Nov; 148(48):12. PubMed ID: 17615761
[No Abstract] [Full Text] [Related]
4. Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal.
Sukel MP; van der Linden MW; Chen C; Erkens JA; Herings RM
Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):9-19. PubMed ID: 17963198
[TBL] [Abstract][Full Text] [Related]
5. [Overestimated].
Höer A; Häussler B
Med Klin (Munich); 2006 Aug; 101(8):676-7; author reply 678-9. PubMed ID: 17051671
[No Abstract] [Full Text] [Related]
6. Stroke caused by small vessel occlusion in a patient taking etoricoxib and thalidomide.
Wong EH; Leung TW; Wong KS
J Neuroimaging; 2007 Jan; 17(1):87-8. PubMed ID: 17238877
[TBL] [Abstract][Full Text] [Related]
7. [Effective pain management after hallux valgus correction].
Mertens E
Pflege Z; 2012 Jun; 65(6):339. PubMed ID: 22741330
[No Abstract] [Full Text] [Related]
8. [Assessment and truth -- how many cardio- and cerebrovascular events are in fact to be led back to taking rofecoxib].
Mühlbauer B; Timm J
Med Klin (Munich); 2006 Aug; 101(8):673-5; author reply 678-9. PubMed ID: 17051669
[No Abstract] [Full Text] [Related]
9. [How many harmed by rofecoxib in Germany?].
Scharnetzky E; Andersohn F; Schill W; Garbe E; Pigeot I
Med Klin (Munich); 2006 Aug; 101(8):675-6; author reply 678-9. PubMed ID: 17051670
[No Abstract] [Full Text] [Related]
10. Adverse effects of etoricoxib: other considerations.
Kim JA; Choi YS; Kim SH
Mayo Clin Proc; 2005 Sep; 80(9):1233-4; author reply 1234. PubMed ID: 16178505
[No Abstract] [Full Text] [Related]
11. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
Hur C; Chan AT; Tramontano AC; Gazelle GS
Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
[TBL] [Abstract][Full Text] [Related]
12. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
El Miedany Y; Youssef S; Ahmed I; El Gaafary M
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
[TBL] [Abstract][Full Text] [Related]
13. Balancing the cyclooxygenase portfolio.
Armstrong PW
CMAJ; 2006 May; 174(11):1581-2. PubMed ID: 16717266
[No Abstract] [Full Text] [Related]
14. Cardiac risks with COX-2 inhibitors.
Ashworth AJ
CMAJ; 2007 Feb; 176(4):489-92. PubMed ID: 17296963
[No Abstract] [Full Text] [Related]
15. Primary stabbing headache can be responsive to etoricoxib, a selective COX-2 inhibitor.
O'Connor MB; Murphy E; Phelan MJ; Regan MJ
Eur J Neurol; 2008 Jan; 15(1):e1. PubMed ID: 18171381
[No Abstract] [Full Text] [Related]
16. Cerebrovascular events after discontinuation of rofecoxib treatment.
Andersohn F
Cardiovasc Drugs Ther; 2007 Apr; 21(2):77-9. PubMed ID: 17404824
[No Abstract] [Full Text] [Related]
17. NSAID trials and the choice of comparators--questions of public health importance.
Psaty BM; Weiss NS
N Engl J Med; 2007 Jan; 356(4):328-30. PubMed ID: 17251528
[No Abstract] [Full Text] [Related]
18. [Coronary risks with NSAID and coxibs. The end of hysteria].
Einecke D
MMW Fortschr Med; 2006 Nov; 148(48):10, 12. PubMed ID: 17615760
[No Abstract] [Full Text] [Related]
19. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
[TBL] [Abstract][Full Text] [Related]
20. Introduction - The coxib controversies.
Rainsford KD
Inflammopharmacology; 2005; 13(4):331-41. PubMed ID: 16354388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]